News from the Western States Node: Webinar on CTN-0108 (TMS for Stimulant Use Disorder), June 25, 2025 (11am PT)
Join the CTN Western States Node, Northwest ATTC, and Pacific Southwest ATTC for their next joint webinar: CTN-0108: Transcranial Magnetic Stimulation in the Treatment of Stimulant Use Disorder (June 25, 2025, 11am-12:30pm PT).
1.5 CME/CE credits available. Accreditation information.
In this session, Kathleen T. Brady, MD, PhD, of the Medical University of South Carolina, will discuss the NIDA N Clinical Trials Network (CTN) study CTN-0108, “Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder,” a pilot study that aims to determine the feasibility, effectiveness, and safety for 20 sessions of repetitive transcranial magnetic stimulation (rTMS) versus sham in adults with a diagnosed methamphetamine or cocaine use disorder.
Dr. Brady, co-Principal Investigator for CTN-0108, will present the rationale for the study, including the literature supporting the use of rTMS in stimulant use disorder, as well as the study methodology and preliminary results.
Objectives:
- List 3 key research findings supporting the use of TMS in treating substance use disorders
- Describe at least 3 key elements of the methodology for a trial of TMS in treating simulant use disorders
- Identify at least 3 preliminary data points from the CTN-0108 study
Register for the CTN-0108 webinar
Posted on May 8, 2025.